Belén Atienza‐Mateo

Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

N. Vegas-Revenga, V. Calvo-Río, Marina Mesquida et al. · American Journal of Ophthalmology · 2019 · 111 citations · Full text

Ocular Disease, Ophthalmology, Anti-il6-receptor Tocilizumab +5

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

Belén Atienza‐Mateo, J. L. Martín-Varillas, V. Calvo-Río et al. · Arthritis & Rheumatology · 2019 · 105 citations · Full text

Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet’s disease: multicentre retrospective study

Belén Atienza‐Mateo, V. Calvo-Río, E. Beltrán et al. · Lara D. Veeken · 2018 · 104 citations

Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients

L. Sánchez-Bilbao, D. Martínez-López, Marcelino Revenga et al. · Journal of Clinical Medicine · 2020 · 81 citations · Full text

Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

J. L. Martín-Varillas, V. Calvo-Río, E. Beltrán et al. · Ophthalmology · 2018 · 65 citations · Full text

Autoimmune Disease, Ophthalmology, Immunology +6